Matsumoto, T.; Yamamura, S.; Ikoma, T.; Kurioka, Y.; Doi, K.; Boku, S.; Shibata, N.; Nagai, H.; Shimada, T.; Tsuduki, T.;
et al. Real-World Data of Trastuzumab Deruxtecan for Advanced Gastric Cancer: A Multi-Institutional Retrospective Study. J. Clin. Med. 2022, 11, 2247.
https://doi.org/10.3390/jcm11082247
AMA Style
Matsumoto T, Yamamura S, Ikoma T, Kurioka Y, Doi K, Boku S, Shibata N, Nagai H, Shimada T, Tsuduki T,
et al. Real-World Data of Trastuzumab Deruxtecan for Advanced Gastric Cancer: A Multi-Institutional Retrospective Study. Journal of Clinical Medicine. 2022; 11(8):2247.
https://doi.org/10.3390/jcm11082247
Chicago/Turabian Style
Matsumoto, Toshihiko, Shogo Yamamura, Tatsuki Ikoma, Yusuke Kurioka, Keitaro Doi, Shogen Boku, Nobuhiro Shibata, Hiroki Nagai, Takanobu Shimada, Takao Tsuduki,
and et al. 2022. "Real-World Data of Trastuzumab Deruxtecan for Advanced Gastric Cancer: A Multi-Institutional Retrospective Study" Journal of Clinical Medicine 11, no. 8: 2247.
https://doi.org/10.3390/jcm11082247
APA Style
Matsumoto, T., Yamamura, S., Ikoma, T., Kurioka, Y., Doi, K., Boku, S., Shibata, N., Nagai, H., Shimada, T., Tsuduki, T., Tsumura, T., Takatani, M., Yasui, H., & Satake, H.
(2022). Real-World Data of Trastuzumab Deruxtecan for Advanced Gastric Cancer: A Multi-Institutional Retrospective Study. Journal of Clinical Medicine, 11(8), 2247.
https://doi.org/10.3390/jcm11082247